mitoxantrone has been researched along with Atrophy in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calabrese, M | 1 |
Mattisi, I | 1 |
Rinaldi, F | 1 |
Favaretto, A | 1 |
Atzori, M | 1 |
Bernardi, V | 1 |
Barachino, L | 1 |
Romualdi, C | 1 |
Rinaldi, L | 1 |
Perini, P | 1 |
Gallo, P | 1 |
Toledano, A | 1 |
Garaud, P | 1 |
Serin, D | 1 |
Fourquet, A | 1 |
Bosset, JF | 1 |
Miny-Buffet, J | 1 |
Favre, A | 1 |
Azria, D | 1 |
Body, G | 1 |
Le Floch, O | 1 |
Calais, G | 1 |
Hurt, MA | 1 |
Halvorson, RD | 1 |
Petr, FC | 1 |
Cooper, JT | 1 |
Friedman, DJ | 1 |
1 review available for mitoxantrone and Atrophy
Article | Year |
---|---|
Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis'.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Cytarabine; Eccrine Glands; Humans; | 1990 |
1 trial available for mitoxantrone and Atrophy
Article | Year |
---|---|
[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemo | 2006 |
1 other study available for mitoxantrone and Atrophy
Article | Year |
---|---|
Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis.
Topics: Adolescent; Adult; Antineoplastic Agents; Atrophy; Cerebellum; Disability Evaluation; Female; Humans | 2010 |